Bharat Vallabhdas Shah
About Bharat Vallabhdas Shah
Data last updated:
Bharat Vallabhdas Shah is a Director at Centre For Digestive And Kidney Diseases (India) Private Limited (since 2004), Director at Advanced Transplant Diagnostics And Immunogenetics Private Limited (since 2019) and Director at Atdi Lab Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Healthcare and Non-Profit Organizations. The 4 current companies with reported revenue have a combined latest revenue of ₹300 Cr; the largest is Centre For Digestive And Kidney Diseases (India) Private Limited at ₹294 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Centre For Digestive And Kidney Diseases (India) Private Limited U85110MH2004PTC146014 | Director | 30 Apr 2004 | 2004 | ₹294 Cr (FY 2023) | Active |
 Advanced Transplant Diagnostics And Immunogenetics Private Limited U93090MH2019PTC330328 | Director | 09 Sep 2019 | 2019 | ₹2.72 Cr (FY 2025) | Active |
| Atdi Lab Private Limited U85300MH2020PTC351304 | Director | 04 Dec 2020 | 2020 | ₹2.09 Cr (FY 2025) | Active |
| Advanced Renal Replacement Therapies Center Private Limited U86100MH2023PTC399580 | Director | 25 Mar 2023 | 2023 | ₹65 Lakh (FY 2025) | Active |
| Atdi Sambhaji Nagar Lab Private Limited U86100MH2024PTC425760 | Director | 05 Jul 2024 | 2024 | Active |
Board colleagues of Bharat Vallabhdas Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bharat Vallabhdas Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharat Vallabhdas Shah
Bharat Vallabhdas Shah currently holds 5 directorships: Centre For Digestive And Kidney Diseases (India) Private Limited (Director, since 30 Apr 2004, revenue ₹294 Cr (FY 2023)); Advanced Transplant Diagnostics And Immunogenetics Private Limited (Director, since 09 Sep 2019, revenue ₹2.72 Cr (FY 2025)); Atdi Lab Private Limited (Director, since 04 Dec 2020, revenue ₹2.09 Cr (FY 2025)); Advanced Renal Replacement Therapies Center Private Limited (Director, since 25 Mar 2023, revenue ₹65 Lakh (FY 2025)); Atdi Sambhaji Nagar Lab Private Limited (Director, since 05 Jul 2024).
Bharat Vallabhdas Shah was first appointed on 30 Apr 2004 as Director at Centre For Digestive And Kidney Diseases (India) Private Limited. The most recent appointment on record is 05 Jul 2024 at Atdi Sambhaji Nagar Lab Private Limited.
The 4 current companies of Bharat Vallabhdas Shah that report revenue have a combined latest revenue of ₹300 Cr: Centre For Digestive And Kidney Diseases (India) Private Limited ₹294 Cr (FY 2023); Advanced Transplant Diagnostics And Immunogenetics Private Limited ₹2.72 Cr (FY 2025); Atdi Lab Private Limited ₹2.09 Cr (FY 2025); Advanced Renal Replacement Therapies Center Private Limited ₹65 Lakh (FY 2025).
The current boards of Bharat Vallabhdas Shah's companies include Aanchal Agarwal (Centre For Digestive And Kidney Diseases (India) Private Limited), Aanchal Vig (Centre For Digestive And Kidney Diseases (India) Private Limited), Aditya Vijay Shinde (Centre For Digestive And Kidney Diseases (India) Private Limited), Arun Kumar Kodipaka (Centre For Digestive And Kidney Diseases (India) Private Limited), Ashok Pandit (Centre For Digestive And Kidney Diseases (India) Private Limited), Bipin Prabhakar Chevale (Centre For Digestive And Kidney Diseases (India) Private Limited), among others.